Assignee
ARCUTIS INC
US·9 granted patents·1 pending application·217 citations·filing 2017–2020
Top patents by PatentIndex Score
10 records- 0199US11793796B2Inhibition of crystal growth of roflumilastARCUTIS INC·Filed 2020·Granted Oct 24, 2023·18 cites·13 claims
- 0299US10940142B2Inhibition of crystal growth of roflumilastARCUTIS INC·Filed 2018·Granted Mar 9, 2021·19 cites·14 claims
- 0398US10105354B1Inhibition of crystal growth of roflumilastARCUTIS INC·Filed 2017·Granted Oct 23, 2018·23 cites·14 claims
- 0498US9907788B1Inhibition of crystal growth of roflumilastARCUTIS INC·Filed 2017·Granted Mar 6, 2018·31 cites·17 claims
- 0598US9895359B1Inhibition of crystal growth of roflumilastARCUTIS INC·Filed 2017·Granted Feb 20, 2018·35 cites·16 claims
- 0698US9884050B1Inhibition of crystal growth of roflumilastARCUTIS INC·Filed 2017·Granted Feb 6, 2018·30 cites·12 claims
- 0797US10172841B2Inhibition of crystal growth of roflumilastARCUTIS INC·Filed 2017·Granted Jan 8, 2019·21 cites·19 claims
- 0896US11534493B2Pharmaceutical compositions of roflumilast in aqueous blends of water-miscible, pharmaceutically acceptable solventsARCUTIS INC·Filed 2017·Granted Dec 27, 2022·19 cites·2 claims
- 0996US11129818B2Topical roflumilast formulation having improved delivery and plasma half lifeARCUTIS INC·Filed 2020·Granted Sep 28, 2021·21 cites·14 claims
- 1062US2020155524A1Method for reducing side effects from administration of phosphodiesterase-4 inhibitorsARCUTIS INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →